BREAKING: Financial Barriers to Prostate Cancer Screenings Removed for Maryland Men May 7, 2020 FOR IMMEDIATE RELEASEMEDIA CONTACT:Ilana Ostrin202-657-2249ilana@zerocancer.org ZERO leads effort to help Maryland make history, becoming the second state in the nation to eliminate cost-sharing for prostate cancer screeningsANNAPOLIS, MD, May 6, 2020 – ZERO Prostate Cancer is proud to have led significant advocacy efforts in the state of Maryland that have resulted in new lifesaving legislation. Starting in 2021, health insurers in each Maryland County must cover the full costs of prostate cancer screenings for men ages 40-75. This legislation gives prostate cancer parity to several women’s cancers (including breast and ovarian) which offer screenings with no attached co-pays or other cost-sharing fees. Senator Malcolm Augustine and Delegate Erek L. Barron sponsored the effort.“This critical bill can save the lives of many Maryland men, as Maryland had the eighth-highest incidence rate of prostate cancer in the nation last year,” said ZERO CEO Jamie Bearse. “Removing barriers -- especially financial roadblocks -- makes early detection more accessible and affordable for men, and helps save lives. Early detection is key to survival as 99 percent of men survive at least five years when prostate cancer is caught early.”On the contrary, when prostate cancer is not caught until late-stage, it has only a 30 percent five-year survival rate. Often, there are no symptoms of prostate cancer before it reaches a late-stage, making early detection essential.In an op-ed published earlier this spring in The Baltimore Sun, Senator Augustine and Delegate Barron purported that, “There is no better time to make screenings for this devastating disease more accessible and affordable as prostate cancer deaths and incidences are on the rise. This year in Maryland, nearly 4,500 men will be diagnosed with the disease — a number that’s already up 5% from last year.”This legislation was supported by Maryland’s insurers, as it would have a nominal impact on their bottom line. A Maryland Healthcare Commission study found that eliminating cost-sharing for these tests would only cost insurers three cents per month or 35 cents per year on premiums. Further, early screening has been proven to be more cost-effective than treating late stages of the disease in multiple studies.ZERO is grateful to Maryland Governor Larry Hogan for his support of the new legislation. ZERO is also grateful to the Maryland General Assembly for passing the bill, and to bill sponsors Senator Augustine and Delegate Barron for championing this effort.Similar efforts to eliminate cost-sharing for prostate cancer screening are already underway elsewhere with the help of ZERO. Earlier this spring, Illinois introduced a similar effort, and advocates in California plan to push cost-sharing legislation later this year. In both states, ZERO will lead the effort with grassroots advocacy and support from the community. For more information on advocacy efforts regarding prostate cancer across the nation, visit our Advocacy page. About ZERO Prostate CancerZERO Prostate Cancer (ZERO) is on a mission to improve and save lives from prostate cancer through advocacy, education, awareness, and support. Formerly known as the National Prostate Cancer Coalition, ZERO was founded in 1996 to stand up for people impacted by prostate cancer. Today, ZERO serves as the nation's leading prostate cancer organization, advancing a future where prostate cancer detection is early, support is unwavering, and care is accessible to all. For almost 30 years, ZERO has led the way in prostate cancer advocacy and support, successfully unlocking funding toward breakthrough discoveries, treatments, and lifesaving access to care.As the nation's #1 provider of prostate cancer resources, programs, and services, ZERO has supported millions of people at-risk or diagnosed, and their families. As the voice of the prostate cancer community, ZERO's urgent focus on breaking barriers to survival—by closing gaps in diagnosis, treatment, and care—brings critical attention to those most likely to be impacted by this disease. Learn more at ZEROCancer.org. Press Release
FOR IMMEDIATE RELEASEMEDIA CONTACT:Ilana Ostrin202-657-2249ilana@zerocancer.org ZERO leads effort to help Maryland make history, becoming the second state in the nation to eliminate cost-sharing for prostate cancer screeningsANNAPOLIS, MD, May 6, 2020 – ZERO Prostate Cancer is proud to have led significant advocacy efforts in the state of Maryland that have resulted in new lifesaving legislation. Starting in 2021, health insurers in each Maryland County must cover the full costs of prostate cancer screenings for men ages 40-75. This legislation gives prostate cancer parity to several women’s cancers (including breast and ovarian) which offer screenings with no attached co-pays or other cost-sharing fees. Senator Malcolm Augustine and Delegate Erek L. Barron sponsored the effort.“This critical bill can save the lives of many Maryland men, as Maryland had the eighth-highest incidence rate of prostate cancer in the nation last year,” said ZERO CEO Jamie Bearse. “Removing barriers -- especially financial roadblocks -- makes early detection more accessible and affordable for men, and helps save lives. Early detection is key to survival as 99 percent of men survive at least five years when prostate cancer is caught early.”On the contrary, when prostate cancer is not caught until late-stage, it has only a 30 percent five-year survival rate. Often, there are no symptoms of prostate cancer before it reaches a late-stage, making early detection essential.In an op-ed published earlier this spring in The Baltimore Sun, Senator Augustine and Delegate Barron purported that, “There is no better time to make screenings for this devastating disease more accessible and affordable as prostate cancer deaths and incidences are on the rise. This year in Maryland, nearly 4,500 men will be diagnosed with the disease — a number that’s already up 5% from last year.”This legislation was supported by Maryland’s insurers, as it would have a nominal impact on their bottom line. A Maryland Healthcare Commission study found that eliminating cost-sharing for these tests would only cost insurers three cents per month or 35 cents per year on premiums. Further, early screening has been proven to be more cost-effective than treating late stages of the disease in multiple studies.ZERO is grateful to Maryland Governor Larry Hogan for his support of the new legislation. ZERO is also grateful to the Maryland General Assembly for passing the bill, and to bill sponsors Senator Augustine and Delegate Barron for championing this effort.Similar efforts to eliminate cost-sharing for prostate cancer screening are already underway elsewhere with the help of ZERO. Earlier this spring, Illinois introduced a similar effort, and advocates in California plan to push cost-sharing legislation later this year. In both states, ZERO will lead the effort with grassroots advocacy and support from the community. For more information on advocacy efforts regarding prostate cancer across the nation, visit our Advocacy page.
About ZERO Prostate CancerZERO Prostate Cancer (ZERO) is on a mission to improve and save lives from prostate cancer through advocacy, education, awareness, and support. Formerly known as the National Prostate Cancer Coalition, ZERO was founded in 1996 to stand up for people impacted by prostate cancer. Today, ZERO serves as the nation's leading prostate cancer organization, advancing a future where prostate cancer detection is early, support is unwavering, and care is accessible to all. For almost 30 years, ZERO has led the way in prostate cancer advocacy and support, successfully unlocking funding toward breakthrough discoveries, treatments, and lifesaving access to care.As the nation's #1 provider of prostate cancer resources, programs, and services, ZERO has supported millions of people at-risk or diagnosed, and their families. As the voice of the prostate cancer community, ZERO's urgent focus on breaking barriers to survival—by closing gaps in diagnosis, treatment, and care—brings critical attention to those most likely to be impacted by this disease. Learn more at ZEROCancer.org.
